IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $205,000 | +54.1% | 7,402 | +1.4% | 0.00% | 0.0% |
| Q3 2019 | $133,000 | -29.6% | 7,300 | -5.2% | 0.00% | 0.0% |
| Q2 2019 | $189,000 | +195.3% | 7,700 | +14.9% | 0.00% | – |
| Q1 2019 | $64,000 | +1.6% | 6,700 | -6.5% | 0.00% | -100.0% |
| Q4 2018 | $63,000 | -31.5% | 7,168 | -12.2% | 0.00% | 0.0% |
| Q3 2018 | $92,000 | -4.2% | 8,168 | +43.3% | 0.00% | 0.0% |
| Q2 2018 | $96,000 | 0.0% | 5,700 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $96,000 | +380.0% | 5,700 | +135.1% | 0.00% | – |
| Q4 2017 | $20,000 | +11.1% | 2,425 | +9.0% | 0.00% | – |
| Q3 2017 | $18,000 | +5.9% | 2,225 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | – | 2,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |